Abstract:BACKGROUND:Two mature microRNAs (miRNAs), hsa-miR-125a-3p and hsa-miR-125a-5p (collectively referred to as hsa-miR-125a-3p/5p), are derived from 3' and 5' ends of pre-miR-125a, respectively. Although impaired regulation of hsa-miR-125a-5p has been observed in some tumors, the role of this miRNA in invasion and metastasis remains unclear, and few studies have examined the function of hsa-miR-125a-3p. In order to characterize the functions of hsa-miR-125a-3p/5p in invasion and metastasis of non-small cell lung cancer (NSCLC), we investigated the relationships between hsa-miR-125a-3p/5p expression and lymph node metastasis in NSCLC tissues. We also explored the impact of expression of these miRNAs on invasive and migratory capabilities of lung cancer cells.METHODS:Expression of hsa-miR-125a-3p/5p in NSCLC tissues was explored using real-time PCR. The relationships between hsa-miR-125a-3p/5p expression and pathological stage or lymph node metastasis were assessed using the Spearman correlation test. For in vitro studies, lung cancer cells were transfected with sense and antisense 2'-O-methyl oligonucleotides for gain-of-function and loss-of-function experiments. Transwell experiments were performed to evaluate cellular migration and invasion.RESULTS:Expression of hsa-miR-125a-3p/5p was lower in NSCLC tissues than in adjacent normal lung tissues (LAC). Furthermore, the results from the Spearman correlation test showed a negative relationship between hsa-miR-125a-3p expression and pathological stage or lymph node metastasis and an inverse relationship between hsa-miR-125a-5p expression and pathological stage or lymph node metastasis. In vitro gain-of-function experiments indicated that hsa-miR-125a-3p and hsa-miR-125a-5p function in an opposing manner, suppressing or enhancing cell migration and invasion in A549 and SPC-A-1 cell lines, respectively. These opposing functions were further validated by suppression of hsa-miR-125a-3p and hsa-miR-125a-5p expression in loss-of-function experiments.CONCLUSION:Hsa-miR-125a-3p and hsa-miR-125a-5p play distinct roles in regulation of invasive and metastatic capabilities of lung cancer cells, consistent with the opposing correlations between the expression of these miRNAs and lymph node metastasis in NSCLC. These results provide new insights into the roles of miR-125a family members in the development of NSCLC.

MicroRNA-125b may function as an oncogene in lung cancer cells.

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

MicroRNA-125a-3p Downregulation Correlates with Tumorigenesis and Poor Prognosis in Patients with Non-Small Cell Lung Cancer

MicroRNA-1253 Suppresses Cell Proliferation and Invasion of Non-Small-cell Lung Carcinoma by Targeting WNT5A

MicroRNA-125b Promotes Tumor Metastasis Through Targeting Tumor Protein 53-Induced Nuclear Protein 1 in Patients with Non-Small-cell Lung Cancer

MicroRNA-125b Promotes Apoptosis by Regulating the Expression of Mcl-1, Bcl-w and IL-6R

MicroRNA-125b expression in gastric adenocarcinoma and its effect on the proliferation of gastric cancer cells.

Overexpression of microRNA‑125a‑3p effectively inhibits the cell growth and invasion of lung cancer cells by regulating the mouse double minute 2 homolog/p53 signaling pathway.

Downregulation of Mir-125B-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.

Effects of miR-1253 on proliferation,migration and invasion of lung adenocarcinoma cells

Mir-125B is Associated with Renal Cell Carcinoma Cell Migration, Invasion and Apoptosis

MicroRNA-125b Induces Cancer Cell Apoptosis Through Suppression of Bcl-2 Expression.

P2.03b-079 Decreased Expression of miR-125a-3p is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients

The Expression and Regulation of Microrna-125b in Cancers

Prognostic Value of Microrna-125 in Various Human Malignant Neoplasms: A Meta-Analysis

Hsa-miR-125a-3p and Hsa-Mir-125a-5p Are Downregulated in Non-Small Cell Lung Cancer and Have Inverse Effects on Invasion and Migration of Lung Cancer Cells.

P2.03b-079 Decreased Expression of miR-125a-3p is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients: Topic: Biomarkers

Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer.

MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways

Prognostic Role of Microrna 125 B Invarious Cancers : a Meta-Analysis

Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9